ASCO issues guideline for febrile neutropenia in adults

January 15, 2013
ASCO issues guideline for febrile neutropenia in adults
The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations have been published online Jan. 14 in the Journal of Clinical Oncology.

(HealthDay)—The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations have been published online Jan. 14 in the Journal of Clinical Oncology.

Christopher R. Flowers, M.D., from Emory University in Atlanta, and colleagues conducted a literature review and identified 43 studies assessing development of fever and/or infections in afebrile neutropenic outpatients with cancer, or treatment of fever and in outpatients with cancer. Data extracted from the studies were used to inform guidelines.

The recommends that antibacterial and antifungal prophylaxis should only be used for patients expected to have <100 neutrophils/µL for more than seven days, unless other factors increase risks for complications or mortality to similar levels. Febrile neutropenic episodes should be managed with inpatient treatment, although carefully selected patients may be managed as outpatients, including those with a Multinational Association for Supportive Care in Cancer score of 21 or higher or those in Talcott's rules group 4. Initial doses of empirical antibacterial therapy should be received by febrile neutropenic patients within an hour of triage, and they should either be monitored for at least four hours to determine suitability for outpatient management or admitted to the hospital. Empiric therapy should include an oral fluoroquinolone plus amoxicillin/clavulanate (or plus clindamycin if penicillin allergic), unless fluoroquinolone prophylaxis was used before fever developed.

"One major limitation of the evidence available to inform this guideline is the absence of data from that either studied the net effect on or compared the efficacy and safety of alternative regimens for antibacterial prophylaxis specifically in afebrile neutropenic outpatients," the authors write.

Explore further: New guidelines issued for pediatric fever and neutropenia

More information: Abstract
Full Text

Related Stories

New guidelines issued for pediatric fever and neutropenia

September 19, 2012
(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; the guidelines ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

ASCO issues recommendations to improve cancer survivor care

January 10, 2013
(HealthDay)—The American Society of Clinical Oncology (ASCO) has presented recommendations for promoting high-quality cancer survivorship care in a report published online Jan. 7 in the Journal of Clinical Oncology.

New findings highlight the challenges of managing blood clotting in cancer patients

October 1, 2012
New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

New guidelines issued for biopsy use in melanoma patients

July 9, 2012
(HealthDay) -- Sentinel lymph node biopsy -- a minimally invasive surgical technique that lets doctors see whether cancer has spread -- should be performed on patients with melanoma tumors of intermediate thickness and may ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.